Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report

We report the case of a 73-year-old woman with PPC who showed a favorable response to nivolumab. As first-line treatment for postoperative recurrence, she received carboplatin and nanoparticle albumin-bound paclitaxel. However, 12 months later, a new metastatic lymph node appeared. Nivolumab was administered as second-line treatment, and the patient showed a favorable prolonged response. The effects of treatment of PPC with nivolumab seem promising. The results of a future prospective study are expected to identify indicators for the treatment of PPC.Case Rep Oncol 2018;11:336 –340
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research